Nomura Holdings’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.05M Buy
137,500
+99,000
+257% +$4.69M 0.01% 633
2025
Q4
$1.96M Hold
38,500
﹤0.01% 1106
2025
Q3
$2.14M Buy
38,500
+32,900
+588% +$1.93M ﹤0.01% 1118
2025
Q2
$387K Sell
5,600
-4,200
-43% -$286K ﹤0.01% 1185
2025
Q1
$681K Sell
9,800
-145,000
-94% -$12M ﹤0.01% 1389
2024
Q4
$13.3M Buy
154,800
+152,300
+6,092% +$16.5M 0.02% 426
2024
Q3
$298K Buy
+2,500
New +$333K ﹤0.01% 1344
2024
Q2
Sell
-99,600
Closed -$12.8M 1950
2024
Q1
$12.8M Buy
99,600
+16,500
+20% +$1.96M 0.03% 372
2023
Q4
$8.6M Buy
83,100
+63,100
+316% +$6.24M 0.02% 492
2023
Q3
$1.82M Buy
+20,000
New +$1.76M 0.01% 811
2023
Q2
Sell
-164,800
Closed -$13.1M 1548
2023
Q1
$13.1M Buy
+164,800
New +$11.7M 0.04% 291
2022
Q4
Sell
-110,600
Closed -$5.51M 1622
2022
Q3
$5.51M Buy
+110,600
New +$5.92M 0.02% 521
2021
Q3
Sell
-56,200
Closed -$2.35M 2141
2021
Q2
$2.35M Buy
+56,200
New +$2.18M 0.01% 809
2019
Q4
Sell
-122,800
Closed -$3.11M 1263
2019
Q3
$3.11M Buy
+122,800
New +$3.11M 0.01% 561

Other funds holding NVO

Nomura Holdings's NVO Position: Q1 2026 in Review

Nomura Holdings increased its Novo Nordisk (NVO) stake by 30% in Q1 2026, buying an estimated $5.02M and bringing the position to 462,909 shares worth $17M. The position accounts for 0.05% of the portfolio, ranked #290.

Nomura Holdings first reported a position in NVO in Q2 2013 and has held it in 18 quarters since. The position peaked at $54.1M in Q3 2025. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Nomura Holdings held 462,909 shares of Novo Nordisk worth $17M as of Q1 2026.
  • Nomura Holdings bought 106,023 Novo Nordisk shares in Q1 2026, an estimated $5.02M.
  • Novo Nordisk made up 0.05% of Nomura Holdings's portfolio in Q1 2026, its #290 holding.
  • Nomura Holdings first reported a position in Novo Nordisk in Q2 2013 and has held it in 18 quarters since.
  • Nomura Holdings's Novo Nordisk position peaked at $54.1M in Q3 2025.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.